Otsuka Holdings Co., Ltd. (TYO: 4578)

Japan flag Japan · Delayed Price · Currency is JPY
8,483.00
-51.00 (-0.60%)
Dec 20, 2024, 3:45 PM JST
62.95%
Market Cap 4.57T
Revenue (ttm) 2.27T
Net Income (ttm) 151.58B
Shares Out 538.68M
EPS (ttm) 279.38
PE Ratio 30.36
Forward PE 16.61
Dividend 120.00 (1.41%)
Ex-Dividend Date Dec 27, 2024
Volume 2,780,100
Open 8,520.00
Previous Close 8,534.00
Day's Range 8,376.00 - 8,535.00
52-Week Range 5,030.00 - 9,669.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 14, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr... [Read more]

Sector Healthcare
Founded 1921
Employees 34,388
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4578
Full Company Profile

Financial Performance

In 2023, Otsuka Holdings's revenue was 2.02 trillion, an increase of 16.14% compared to the previous year's 1.74 trillion. Earnings were 121.62 billion, a decrease of -9.18%.

Financial Statements

News

Otsuka Holdings Co., Ltd. reports Q3 results

Otsuka Holdings Co., Ltd. reported a significant increase in revenue and profit for the nine-month period ended September 30.

7 weeks ago - Seeking Alpha

Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific

Otsuka Holdings Co. is considering options for its holding in Hong Kong-listed MicroPort Scientific Corp., including selling its stake in the medical device maker, according to people familiar with th...

2 months ago - BNN Bloomberg